FDC Limited share price

FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastroenterology, ophthalmology, anti-diabetics, cardiovascular care, respiratory care, gynaecology, dermatology, paediatrics, analgesics, vitamins, and nutritional health in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured oral rehydration solution powders, ready-to-drink electrolyte beverages, vitamin-enriched suppleme…Read more

Website NSE हिंदी में BSE

HealthcareDrug Manufacturers - Specialty & GenericNSE: FDCISIN INE258B01022

16 Oct 2026, 3:30 PM IST₹356.25▲ 4.85 (1.38%)

Market Cap₹ 5,800 Cr.
Current Price₹ 356.25
High / Low₹ 474 / 313
Stock P/E19.8
Book Value₹ 153
Dividend Yield2.85 %
ROCE14.8 %
ROE11.80 %
Face Value₹ 1.0

More figures (10)

EPS (TTM)₹ 17.98
Price / Book2.33
OPM13.3 %
Debt / Equity0.01
Sales growth (5Y)10.2 %
Profit growth (5Y)-1.3 %
Promoter holding69.9 %
EV / EBITDA15.0
Beta0.20
All-time high₹ 659

Price chart

Price on NSE 50 DMA 200 DMA Volume

Returns	1M	3M	6M	YTD	1Y	3Y CAGR	5Y CAGR
FDC	+1.73%	-15.52%	+0.13%	-15.80%	-18.24%	-2.93%	+0.14%
Nifty 50	-0.31%	-3.85%	-4.34%	-11.42%	-9.53%	+5.46%	+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

FDC Limited is in the Drug Manufacturers - Specialty & Generic industry (Healthcare), with a market value of ₹5,800 crore.
It trades at 19.8 times its last 12 months' earnings and 2.3 times book value.
Revenue grew 10.2% a year over the last 5 years, profit -1.3% a year.
Return on equity was 11.8% and return on capital employed 14.8% in the latest year.
Debt was 0.01 times shareholders' equity.
The share price is 24.8% below its 52-week high and down 18.2% over one year.
Promoters and insiders hold about 69.9%; institutions about 7.4%.

Pros

Company is almost debt-free (debt is 0.01 times equity).
Trades at 19.8 times earnings, below its 3-year median of 27.3.
Promoters hold a large stake of 69.66%.

Cons

Profit growth has been weak: -1.3% a year over the last 5 years.
Other income makes up 36% of profit before tax.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About FDC Limited

Employees: 7,076
Head office: Mumbai

HealthcareDrug Manufacturers - Specialty & Generic

S.No.	Company	CMP ₹	P/E	Mar Cap ₹ Cr	Div Yld %	NP Qtr ₹ Cr	Qtr Profit Var %	Sales Qtr ₹ Cr	Qtr Sales Var %	ROCE %	ROE %	P/B	OPM %	Debt / Eq	Prom. Hold. %	Sales ₹ Cr	Sales Var 3Yrs %
1.	FDC	356.25	19.8	5,800	2.85	132	9.18	668	2.97	14.8	11.8	2.33	13.3	0.01	69.94	2,171	10.2
2.	Sun Pharmaceutical Industries	1,758.80	34.9	4,21,995	0.91	2,895	34.65	15,184	18.48	17.9	14.7	5.05	23.4	0.06	55.61	58,220	10.4
3.	Divi's Laboratories	9,144.50	83.0	2,42,758	0.33	902	36.25	3,080	19.15	19.0	16.2	14.48	28.4	0.00	52.00	10,476	11.0
4.	Torrent Pharmaceuticals	4,558.90	72.8	1,73,406	0.83	566	3.28	4,921	54.85	9.1	27.1	18.39	25.0	1.79	63.18	13,980	13.3
5.	Zydus Lifesciences	1,123.00	25.0	1,12,020	0.09	940	-19.74	7,802	24.03	19.0	19.7	4.17	21.7	0.46	75.18	26,720	16.5
6.	Laurus Labs	2,060.10	101.8	1,11,310	0.12	362	123.94	2,026	29.10	19.5	18.2	20.98	19.4	0.48	32.03	6,813	3.8
7.	Cipla	1,325.10	31.8	1,07,051	0.98	789	-35.42	7,077	7.26	14.9	11.8	3.11	17.5	0.02	31.13	27,712	7.2
8.	Dr. Reddy's Laboratories	1,233.00	31.0	1,02,707	0.66	444	-68.72	8,071	-5.56	14.2	12.1	2.68	14.9	0.21	30.14	33,593	11.0
9.	Aurobindo Pharma	1,666.90	26.0	95,910	0.00	1,033	14.29	9,106	8.65	13.5	9.9	2.56	15.6	0.21	54.79	33,385	10.7
10.	Mankind Pharma	2,275.50	46.0	93,988	0.00	574	29.12	4,031	12.89	13.7	12.5	5.76	19.9	0.39	75.39	14,278	17.7
	Median: 50 Co.	1,712.85	31.0	15,877	0.33	682	11.73	5,999	15.68	14.9	13.4	4.02	15.7	0.21	55.20	20,499	12.2

Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.

Quarterly Results

Consolidated figures in ₹ crore /

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	536	486	458	462	638	514	464	492	648	473	465	585	668
YOY Sales Growth %	8.43%	9.30%	11.94%	6.26%	19.00%	5.65%	1.30%	6.46%	1.59%	-7.94%	0.13%	18.89%	2.97%
	414	410	374	406	492	444	417	438	508	439	412	478	525
Material Cost %	34%	35%	33%	33%	36%	36%	35%	33%	32%	31%	33%	35%	32%
Employee Cost %	20%	21%	23%	22%	18%	24%	26%	25%	20%	26%	26%	19%	20%
Other Expenses %	23%	29%	26%	32%	22%	26%	30%	32%	26%	37%	30%	28%	26%
Operating Profit	122	76	84	56	147	70	47	54	140	34	52	106	143
OPM %	23%	16%	18%	12%	23%	14%	10%	11%	22%	7%	11%	18%	21%
	29	27	25	20	28	35	19	16	36	21	21	50	48
Exceptional items											-21
Interest	1	1	1	1	1	1	1	1	1	1	1	2	1
Depreciation	10	10	10	10	11	14	13	16	15	15	15	14	15
Profit before tax	141	93	98	65	163	90	51	53	160	38	36	140	175
	22%	25%	19%	29%	27%	20%	28%	27%	24%	26%	22%	26%	24%
Current tax	31	24	21	14	37	20	14	16	35	11	9	31	40
Deferred tax	0	-1	-2	5	7	-2	1	-1	3	-1	-1	6	2
	110	70	79	46	119	72	37	39	121	28	28	103	132
Minority share	-0	-0	-0
Profit to shareholders	110	70	79	46	120	73	37		121				132
YOY Profit Growth %	55.41%	34.75%	94.48%	50.93%	8.40%	3.23%	-53.22%	-16.44%	1.95%	-60.62%	-23.59%	167.37%	9.18%
EPS in Rs	6.62	4.22	4.86	2.84	7.31	4.43	2.28	2.38	7.45	1.75	1.74	6.35	8.14
Raw filing

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	530	480	452	454	624	505	459	482	642	462	458	564	655
YOY Sales Growth %		7.50%	11.22%	5.34%	17.75%	5.30%	1.47%	6.11%	2.91%	-8.58%	-0.20%	17.09%	2.00%
	410	401	370	396	482	433	413	429	501	427	408	453	512
Material Cost %	34%	34%	33%	33%	36%	35%	35%	33%	32%	30%	33%	34%	32%
Employee Cost %	20%	21%	23%	22%	19%	25%	26%	25%	20%	26%	26%	19%	20%
Other Expenses %	23%	29%	26%	32%	22%	26%	29%	31%	25%	36%	30%	27%	26%
Operating Profit	120	79	82	58	142	72	46	53	141	35	50	112	143
OPM %	23%	16%	18%	13%	23%	14%	10%	11%	22%	8%	11%	20%	22%
	30	27	25	21	28	35	19	31	36	21	22	47	47
Exceptional items											-21
Interest	1	1	1	1	1	1	1	1	1	1	1	1	1
Depreciation	10	10	10	10	11	14	13	16	15	15	15	14	15
Profit before tax	139	95	96	67	158	92	50	68	161	39	35	143	174
	22%	24%	19%	28%	27%	20%	28%	29%	24%	25%	22%	25%	24%
Current tax	31	24	20	13	36	20	13	16	35	11	9	31	40
Deferred tax	0	-0	-2	6	7	-2	0	4	4	-1	-1	5	3
	109	72	78	48	115	74	36	48	122	29	27	107	132
YOY Profit Growth %		40.50%	98.77%	29.41%	5.93%	2.68%	-53.50%	0.04%	6.26%	-60.15%	-25.41%	122.07%	8.04%
EPS in Rs	6.54	4.36	4.81	2.97	7.06	4.55	2.24	2.96	7.51	1.81	1.67	6.58	8.11
Raw filing

Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Consolidated figures in ₹ crore /

₹ Cr	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	1,083	1,344	1,333	1,528	1,784	1,943	2,108	2,171	2,190
YOY Sales Growth %		24.11%	-0.82%	14.61%	16.74%	8.92%	8.50%	2.98%
	856	1,051	999	1,274	1,533	1,604	1,783	1,825	1,855
Material Cost %	33%	32%	31%	35%	37%	34%	35%	33%	33%
Employee Cost %	20%	21%	22%	22%	22%	21%	23%	22%	22%
Other Expenses %	27%	26%	22%	26%	27%	28%	27%	29%	30%
Operating Profit	227	293	334	254	251	339	325	346	335
OPM %	21%	22%	25%	17%	14%	17%	15%	16%	15%
	51	69	97	76	50	102	91	114	139
Exceptional items	-0		-2					-21	-21
Interest	1	3	3	3	4	4	5	5	5
Depreciation	35	37	38	37	39	40	54	59	59
Profit before tax	241	321	388	289	258	396	357	375	390
	28%	25%	22%	25%	25%	23%	25%	25%	25%
Current tax	69	84	85	69	69	89	86	86
Deferred tax	-2	-4	1	5	-5	3	4	7
	174	240	301	216	194	305	267	281	293
Profit from associates		-1	0
Minority share			-0	-0	-0	-0
Profit to shareholders		240	301	7	194	305
YOY Profit Growth %		38.25%	25.56%	-28.23%	-10.33%	57.39%	-12.55%	5.49%
EPS in Rs	9.76	13.94	17.72	12.81	11.66	18.58	16.39	17.29	17.98
Dividend Payout %					0%	0%	30%	29%

Compounded Sales Growth

5 Years:: 10%
3 Years:: 7%
TTM:: 3%

Compounded Profit Growth

5 Years:: -1%
3 Years:: 13%
TTM:: 9%

Stock Price CAGR

5 Years:: 0%
3 Years:: -3%
1 Year:: -18%

Return on Equity

4 Years:: 12%
Last Year:: 12%

₹ Cr	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	1,070	1,076	1,331	1,325	1,519	1,777	1,916	2,070	2,126	2,139
YOY Sales Growth %		0.53%	23.72%	-0.42%	14.60%	16.99%	7.83%	8.03%	2.72%
	851	856	1,048	1,001	1,272	1,522	1,578	1,750	1,774	1,800
Material Cost %	33%	32%	32%	31%	35%	37%	34%	35%	32%	32%
Employee Cost %	20%	21%	21%	22%	22%	22%	21%	23%	22%	22%
Other Expenses %	27%	27%	26%	22%	27%	27%	27%	26%	29%	29%
Operating Profit	219	220	284	324	247	255	338	320	352	339
OPM %	20%	20%	21%	24%	16%	14%	18%	15%	17%	16%
	51	55	83	97	79	54	103	106	111	137
Exceptional items		-4							-21	-21
Interest	1	1	3	3	3	4	4	4	5	5
Depreciation	35	33	37	38	37	39	40	54	59	59
Profit before tax	234	236	325	380	285	266	398	368	378	392
	28%	27%	24%	23%	23%	24%	23%	26%	24%	25%
Current tax	68	67	83	85	68	69	88	85	86
Deferred tax	-2	-2	-4	1	-2	-4	3	9	6
	168	172	247	294	220	201	307	274	286	296
YOY Profit Growth %		1.91%	43.86%	19.33%	-25.42%	-8.50%	52.84%	-10.92%	4.49%
EPS in Rs	9.47	9.84	14.34	17.32	13.01	12.09	18.70	16.81	17.56	18.17
Dividend Payout %						0%	0%	30%	28%

Compounded Sales Growth

5 Years:: 10%
3 Years:: 6%
TTM:: 2%

Compounded Profit Growth

5 Years:: -1%
3 Years:: 12%
TTM:: 5%

Stock Price CAGR

5 Years:: 0%
3 Years:: -3%
1 Year:: -18%

Return on Equity

4 Years:: 12%
Last Year:: 12%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	17	16	16	16
Reserves	1,965	2,081	2,265	2,469
	28	21	21	15
Long term borrowings	1	0	0
Short term borrowings	0	0
	333	350	412	418
Trade payables	178	186	205	207
Minority interest	-1
Current liabilities	312	311	362	364
Total Liabilities	2,343	2,468	2,714	2,919
	913	949	1,001	1,134
Gross block	1,173	1,242	1,315	1,494
Accumulated depreciation	260	292	314	360
Goodwill & intangibles	6	4	4	4
CWIP	219	273	153	138
	1,211	1,246	1,560	1,647
Inventories	329	389	375	355
Trade receivables	123	117	109	152
Cash & equivalents	24	25	51	49
Current assets	1,027	1,066	1,089	1,133
Total Assets	2,343	2,468	2,714	2,919

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	155	221	318	200
Profit for the year	194	305	267	281
Working capital changes	-30	-20	88	-54
Direct taxes paid	-77	-104	-103	-87
	11	-17	-200	-110
Fixed assets purchased	-113	-93	-97	-187
Fixed assets sold	5	24	6	27
Investments purchased	-566	-506	-536	-507
Investments sold	662	531	381	508
	-180	-202	-92	-93
Repayment of borrowings	-0	-0	-0	-0
Interest paid	-1	-3	-3	-3
Dividends paid	-0	-0	-81	-81
Net Cash Flow	-14	2	26	-3
Free Cash Flow	42	127	221	14

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROE	—	9.8%	15.0%	12.2%	11.8%
ROCE	—	12.9%	18.5%	15.3%	14.8%
Operating margin	—	11.9%	15.4%	12.9%	13.3%
Net margin	—	10.9%	15.7%	12.7%	13.0%
Debt / equity	—	0.01	0.01	0.01	0.01
Current ratio	—	3.30	3.43	3.01	3.11
Debtor days	—	25	22	19	26
Inventory days	—	175	207	180	175
Days payable	—	95	99	99	102
Cash conversion cycle	—	105	130	100	99
Working capital days	—	147	142	126	130

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

Promoters 69.66%
FIIs 1.40%
DIIs 6.31%
Public 22.63%

%	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	69.66%	69.66%	69.66%	69.66%	69.66%	69.66%	69.66%	69.66%	69.66%	69.66%	69.66%	69.66%
	2.42%	2.43%	2.65%	2.51%	2.62%	2.67%	2.55%	2.41%	2.43%	2.32%	2.40%	1.40%
Foreign portfolio investors (Cat. I)	2.30%	2.32%	2.49%	2.31%	2.40%	2.46%	2.35%	2.28%	2.28%	2.17%	2.23%	1.34%
Foreign portfolio investors (Cat. II)	0.12%	0.11%	0.16%	0.20%	0.22%	0.21%	0.21%	0.13%	0.15%	0.15%	0.17%	0.06%
	8.12%	7.76%	6.94%	6.73%	6.03%	6.08%	6.37%	7.17%	6.82%	6.27%	6.29%	6.31%
Mutual funds	7.93%	7.54%	6.69%	6.51%	5.79%	5.87%	6.18%	6.98%	6.63%	6.21%	6.23%	6.25%
Insurance companies	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.06%	0.06%	0.06%	0.06%
Alternative investment funds	0.12%	0.15%	0.18%	0.14%	0.16%	0.14%	0.12%	0.12%	0.12%
	19.80%	20.15%	20.76%	21.10%	21.70%	21.59%	21.42%	20.76%	21.10%	21.75%	21.65%	22.63%
Retail (up to ₹2 lakh)	11.18%	11.37%	11.78%	11.88%	12.24%	12.12%	11.92%	12.01%	12.25%	12.71%	12.58%	13.41%
HNIs (above ₹2 lakh)	4.75%	4.75%	4.76%	4.84%	4.46%	4.46%	4.30%	4.16%	4.15%	4.26%	4.24%	4.23%
NRIs	1.21%	1.35%	1.58%	1.75%	1.59%	1.63%	1.78%	1.74%	1.82%	1.84%	1.84%	1.86%
Bodies corporate	1.79%	1.81%	1.77%	1.81%	2.53%	2.50%	2.56%	1.98%	1.88%	1.95%	2.01%	2.07%
IEPF	0.22%	0.22%	0.22%	0.22%	0.22%	0.22%	0.30%	0.30%	0.30%	0.30%	0.29%	0.28%
No. of Shareholders	56,928	55,341	52,377	50,634	55,400	55,228	53,880	54,445	54,157	53,788	52,730	55,045

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Mutual funds & institutions holding FDC

Holder (above 1%)	Stake
ICICI PRUDENTIAL SMALLCAP FUNDMutual fund · see the fund house	2.80%
Nippon India Small Cap FundMutual fund	2.63%

As named in the shareholding pattern for Jun 2026 filed with NSE; mutual funds together hold 6.25% of the company. Shareholders below 1% are not named in the filing.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

None filed recently.

Concalls & investor meets

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Ex-dividend date: 11 Feb 2026
Latest quarter: 30 Jun 2026
Financial year end: 31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an account How it works

Latest news

In the news

From the company (NSE)

Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.

Questions about FDC Limited

What is the share price of FDC Limited today?

FDC Limited (FDC) last traded at ₹356.25 on NSE (16 Oct 2026, 3:30 PM IST). Prices may be delayed.

What is the market cap of FDC Limited?

About ₹5,800 crore at the latest price.

What is the P/E ratio of FDC Limited?

About 19.8 times its earnings over the last 12 months.

Is FDC Limited a good investment?

We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.

How can I buy FDC Limited shares?

You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.

Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).

Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Get in touch

We typically respond within 2 hours on business days.

Call us

CA Amit Kumar Jain+91 93522 44475 Arihant Jain+91 80056 49698 Poornima Jain+91 92525 44475

Email ussupport@plenitude.co.in

WhatsAppChat with an expert

Visit us5C, Laxmi Colony, Near Bohra Ji Ka Bagh, Opp. Laxmi Mandir Cinema, Tonk Road, Jaipur, Rajasthan 302015

Mon–Sat · 10:00 AM – 7:00 PM IST

In your free consultation

A health check of your current investments
A goal-based plan for retirement, education or a home
Ways to save tax that fit your situation
Clear next steps, with zero pressure to invest

2,000+Investors

₹250 Cr+Client assets

15+ yrsExperience

AMFI Registered Mutual Fund Distributor · ARN-130934

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

100% free
No obligation
Reply within 2 hours

First name *

Last name *

Email *

Phone *

+91

I'm interested in *

Best day for a call

Preferred time

How can we help? (optional)

Upload your portfolio (optional, get a free expert review)Attach your portfolio statement · PDF, Excel or CSV (e.g. CAS), max 10 MB

I consent to being contacted by Plenitude Connect about financial services. My data will be handled as per the Privacy Policy.

Join 2,000+ investors who plan with Plenitude

Your details are private and never shared.

FDC Limited share price

Price chart

Quick take

Pros

Cons

AI analysis

About FDC Limited

Peer comparison

Quarterly Results

Profit & Loss

Projection — your assumptions

Related party transactions

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Mutual funds & institutions holding FDC

Documents

Announcements

Annual reports

Credit ratings

Concalls & investor meets

Key dates

Trade with our broking desk

Latest news

In the news

From the company (NSE)

Questions about FDC Limited

Have a question about this topic?

Book your free wealth consultation

Request received!

What happens next